Al Chalaby Shahad, Makhija Rakhee R, Sharma Ajay N, Majid Muhammad, Aman Edris, Venugopal Sandhya, Amsterdam Ezra A
Alameda Health System - Highland Hospital, Oakland, CA 94602, USA.
Division of Cardiovascular Medicine, University of California Davis, Davis, CA 95817, USA.
Rev Cardiovasc Med. 2022 Apr 11;23(4):137. doi: 10.31083/j.rcm2304137. eCollection 2022 Apr.
Initially described in 1936, non-bacterial thrombotic endocarditis (NBTE) is a rare entity involving sterile vegetations on cardiac valves. These vegetations are usually small and friable, typically associated with hypercoagulable states of malignancy and inflammatory diseases such as systemic lupus erythematosus. Diagnosis remains challenging and is commonly made post-mortem although standard clinical methods such as echocardiography (transthoracic and transesophageal) and magnetic resonance imaging may yield the clinical diagnosis. Prognosis of NBTE is poor with very high morbidity and mortality usually related to the serious underlying conditions and high rates of systemic embolization. Therapeutic anticoagulation with unfractionated heparin has been described as useful for short term prevention of recurrent embolic events in patients with NBTE but there are no guidelines for management of this disease.
非细菌性血栓性心内膜炎(NBTE)最初于1936年被描述,是一种罕见的病症,涉及心脏瓣膜上的无菌赘生物。这些赘生物通常较小且易碎,典型地与恶性肿瘤及系统性红斑狼疮等炎症性疾病引起的高凝状态相关。尽管超声心动图(经胸和经食管)及磁共振成像等标准临床方法可能得出临床诊断,但NBTE的诊断仍然具有挑战性,且通常是在尸检后才得以确诊。NBTE的预后很差,发病率和死亡率都非常高,这通常与严重的基础疾病及高比例的系统性栓塞有关。使用普通肝素进行治疗性抗凝已被描述为对预防NBTE患者的复发性栓塞事件有用,但对于这种疾病的管理尚无指南。